Marcus Abraitis is the Vice President of Finance of Palladio Biosciences. Marcus has more than 15 years of experience in executive financial and leadership roles, spanning both commercial and clinical stage companies. Most recently he served as the Vice President of Finance at Lycera Corp., a privately held biotechnology company focused on developing autoimmune and immuno-oncology treatments. In his role at Lycera, Marcus was responsible for all financial reporting and supporting numerous mergers and acquisition, licensing and fundraising transactions. Prior to Lycera, he was the Director of Financial Planning and Analysis at moksha8, with responsibilities spanning the company’s US, Brazilian, and Mexican markets.
Marcus holds a BS from Marist College and an MBA from Norwich University.